Lung Cancer

We treat all types and stages of lung cancer, including non-small cell carcinomas, small cell lung cancer, and mediastinal and pleural tumors, including thymoma and mesothelioma. Your treatment may include a combination of chemotherapy, targeted therapies, surgery, radiation therapy, and immunotherapy.

Before creating your treatment plan, we get to know you and learn about your cancer's type, stage, and location. We look at your tumor's genetic makeup and other factors that will influence the treatment choice.

Home to two major academic medical centers, we participate in clinical trials for all types of lung cancer. These studies offer access to investigational therapies that show promise for fighting cancer. Scientists in our laboratories also scrutinize the intricacies of lung cancer development and progression, helping to identify which novel therapies might offer better outcomes for our patients.

Learn more about our clinical trials

Lung cancer screening

Lung cancer screening aims to detect lung cancer in its earliest stages, before an individual experiences symptoms and when treatment is most effective. The National Lung Screening Trial demonstrated that annual screening with low-dose computed tomography (CT) can reduce lung cancer deaths in individuals at high risk for lung cancer by 20%, as opposed to chest x-ray screening. Our lung cancer screening programs offer state-of-the-art low-dose CT imaging interpreted by fellowship-trained experienced radiologists. Learn more about lung cancer screening at NewYork-Presbyterian.